In a patent infringement litigation between rival manufacturers of dermal fillers, CRA was asked to opine on damages suffered by plaintiffs. In an expert report, CRA analyzed lost profits and reasonable royalty damages, examining the market and buying patterns for dermal fillers. In considering the hypothetical negotiation, CRA examined features linked to the patents at issue and other features not subject to the negotiation.
Overview of IP litigation in the US involving Chinese companies
This underscores China’s growing commitment to address intellectual property (IP) disputes with foreign entities. While litigators and companies are evaluating...